126 related articles for article (PubMed ID: 2516705)
21. Therapeutic effects of spironolactone in polycystic ovary syndrome.
Milewicz A; Silber D; Kirschner MA
Obstet Gynecol; 1983 Apr; 61(4):429-32. PubMed ID: 6828272
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Sert M; Tetiker T; Kirim S
Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
[TBL] [Abstract][Full Text] [Related]
23. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
Vĕtr M; Sobek A
Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
[TBL] [Abstract][Full Text] [Related]
24. Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
Spandri P; Gangemi M; Nardelli GB; Meneghetti G; Grandesso R; De Salvia D; Ambrosio GB; Predebon O
Clin Exp Obstet Gynecol; 1984; 11(1-2):49-54. PubMed ID: 6424970
[TBL] [Abstract][Full Text] [Related]
25. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
[TBL] [Abstract][Full Text] [Related]
26. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
Couzinet B; Pholsena M; Young J; Schaison G
Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
[TBL] [Abstract][Full Text] [Related]
27. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
Rubens R
Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
[TBL] [Abstract][Full Text] [Related]
28. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment].
Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R
Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208
[TBL] [Abstract][Full Text] [Related]
29. Endocrine and clinical effects of spironolactone in female hyperandrogenism.
Siegberg R; Ylöstalo P; Laatikainen T; Pelkonen R; Stenman UH
Arch Gynecol; 1987; 240(2):67-73. PubMed ID: 3566358
[TBL] [Abstract][Full Text] [Related]
30. Spironolactone in the treatment of hirsutism.
Anttila L; Ruutiainen K; Erkkola R
Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
Chapman MG; Dowsett M; Dewhurst CJ; Jeffcoate SL
Br J Obstet Gynaecol; 1985 Sep; 92(9):983-5. PubMed ID: 4041402
[TBL] [Abstract][Full Text] [Related]
32. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
Müderris II; Bayram F; Ozçelik B; Güven M
Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
[TBL] [Abstract][Full Text] [Related]
33. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
34. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute and chronic androgen suppression by glucocorticoids on gonadotropin levels in hirsute women.
Karpas AE; Rodriguez-Rigau LJ; Smith KD; Steinberger E
J Clin Endocrinol Metab; 1984 Oct; 59(4):780-4. PubMed ID: 6434580
[TBL] [Abstract][Full Text] [Related]
36. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
37. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
Jones DB; Ibraham I; Edwards CR
Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
[TBL] [Abstract][Full Text] [Related]
39. Ovarian and adrenal contribuion to peripheral steroids during the menstrual cycle in two hirsute women.
Abraham GE
Obstet Gynecol; 1975 Jul; 46(1):29-36. PubMed ID: 1153134
[No Abstract] [Full Text] [Related]
40. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
